Title | Medication Epinephrine |
---|---|
Author | BoB BoBington |
Course | Care Management 2 |
Institution | Keiser University |
Pages | 1 |
File Size | 143.1 KB |
File Type | |
Total Downloads | 96 |
Total Views | 130 |
Active Learning Template...
ACTIVE LEARNING TEMPLATE:
Medication
Gavin Isaac STUDENT NAME _____________________________________ Epinephrine MEDICATION __________________________________________________________________________
REVIEW MODULE CHAPTER ___________
Antianaphylactic, bronchodilator, cardiac stimulant CATEGORY CLASS ______________________________________________________________________ PURPOSE OF MEDICATION
Expected Pharmacological Action Acts on alpha and beta receptors. This nonselective adrenergic agonist stimulates: postsynaptic alpha2 receptors, which constricts arteries.
Therapeutic Use To treat cardiac arrest.
Complications CNS> Anxiety, apprehensiveness, chills, disorientation CV> Arrhythmias, including ventricular fibrillation GI> Anorexia, heartburn, nausea, vomiting
Contraindications/Precautions Epinephrine is contraindicated in patients with cerebral arteriosclerosis, coronary insufficiency, dilated cardiomyopathy, general anesthesia with halogenated hydrocarbons or cyclopropane, sensitivity to epinephrine.
Interactions Rapid acting vasodilators: Blockage of epinephrine’s alpha-adrenergic effect, possibly causing severe hypotension and tachycardia. Antihypertensives: Decreased antihypertensive effect
Medication Administration 0.5 to 1mg of 1:10000 solution every 3 to 5 minutes during resuscitation
Nursing Interventions Use epinephrine cautiously in patients with angina, arrhythmias, asthma, degenerative heart disease or emphysema. Epinephrine’s inotropic effect equals that of dopamine and dobutamine;
Client Education Evaluation of Medication Effectiveness Improved perfusion AEB urine output greater than 30ml,hr with adequate kidney function and improved mental status. Blood pressure maintained within normal limits.
ACTIVE LEARNING TEMPLATES
Warn patient not to exceed recommended dosage or to shorten interval because of the risk of adverse reactions and tolerance
THERAPEUTIC PROCEDURE
A7...